This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: The University of Chicago. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Jun Mao
Introduction
Jun Mao is an accomplished inventor based in Chicago, IL (US). He has made significant contributions to the field of antimicrobial research, particularly through his innovative patent. His work focuses on addressing diseases and disorders caused by microbial pathogens, showcasing his commitment to improving health outcomes.
Latest Patents
Jun Mao holds a patent for "Phosphorylated tri-block copolymers with antimicrobial properties." This patent provides products and methods for treating diseases and disorders involving microbial pathogens, such as gastrointestinal infections and inflammation. The disclosure emphasizes the administration of an effective amount of a phosphorylated polyethylene glycol compound with a defined structural organization. This innovation is particularly relevant for treating conditions characterized by an epithelium attacked by microbial pathogens, including intestinal or esophageal anastomosis and the suppression of anastomotic leakage. Jun Mao has 1 patent to his name.
Career Highlights
Throughout his career, Jun Mao has worked with prestigious institutions, including The University of Chicago and Argonne National Laboratory. His research has contributed to advancements in the understanding and treatment of microbial infections, making a lasting impact in the field.
Collaborations
Jun Mao has collaborated with notable colleagues, including John C. Alverdy and Matthew Tirrell. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Jun Mao's contributions to antimicrobial research through his innovative patent demonstrate his dedication to improving health outcomes. His work continues to influence the field and offers promising solutions for treating microbial-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
